Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
  • A61K8/20—Halogens; Compounds thereof
  • A61K8/21—Fluorides; Derivatives thereof
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/60—Sugars; Derivatives thereof
  • A61K8/602—Glycosides, e.g. rutin
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
  • A61K8/73—Polysaccharides
  • A61K8/731—Cellulose; Quaternized cellulose derivatives

Definitions

• Oral care composition containing at least one biosurfactant and fluoride
• the present invention relates to oral care compositions comprising at least one biosurfactant and fluoride.
• the fluoride ion has been widely used topically in the treatment of dental caries for its
• Fluoride is added into toothpastes mostly as sodium fluoride (NaF), sodium monofluorophosphate (MFP), amine fluoride, and stannous fluoride.
• NaF sodium fluoride
• MFP sodium monofluorophosphate
• amine fluoride amine fluoride
• stannous fluoride stannous fluoride.
• the other ingredients of toothpaste may also affect the availability of fluoride in the oral cavity. This is especially true in the case of calcium containing abrasives due to their potential to inactivate the fluoride.
• fluoride will react with silica to form fluorosilicates if a sufficient amount of detergent is not present.
• Stannous fluoride gels (0.4% SnF ⁇ , equivalent to 970 ppm of fluoride) are effective in arresting root surface caries and have been incorporated into artificial saliva to reduce caries after radiation therapy in cancer patients.
• Stannous fluoride gel has a bad taste and may stain the teeth.
• compositions bear a reduced formation of insoluble complexes of fluoride with for example calcium.
• a further advantage of the present invention is that the compositions induce a reduced staining of teeth.
• a further advantage of the present invention is an improved taste of the compositions.
• a further advantage of the invention is that the compositions have an improved deposition/retention of fluoride on surfaces.
• a further advantage of the present invention is that the compositions reduce dental plaque.
• a further advantage of the present invention is that the compositions reduce oral malodor.
• the present invention relates to oral care compositions containing at least one biosurfactant and at least one fluoride ion source.
• biosurfactant is understood to mean any glycolipid produced by fermentation.
• the oral care compositions can be present in various different forms, including a dentifrice, paste, gel, medicament, powder, mouthrinse, mouthwash, tooth hardener, oral film, slurry, injectable solution, chewing gum and lozenge, as well as any other form of oral care compositions known in the art.
• the composition according to the invention is characterized in that the biosurfactant is selected from the group consisting of rhamnolipids, sophorolipids, glucose lipids, cellulose lipids and trehalose lipids, preferably rhamnolipids and sophorolipids with rhamnolipids being the most preferred.
• the biosurfactants in particular glycolipid surfactants, can be produced e.g. as in EP 0 499 434, US 7,985,722, WO 03/006146, JP 60 183032, DE 19648439, DE 19600743, JP 01 304034, CN 1337439, JP 2006 274233, KR 2004033376, JP 2006 083238, JP 2006 070231 , WO 03/002700, FR 2740779, DE 2939519, US 7,556,654, FR 2855752, EP 1445302, JP 2008 062179 and JP 2007 181789 or the documents cited therein.
• Suitable biosurfactants can be acquired e.g. from Soliance, France and Evonik Industries AG, Germany.
• the composition according to the invention preferably has, as biosurfactants, rhamnolipids, in particular mono-, di- or polyrhamnolipids, and/or sophorolipids.
• the composition according to the invention particularly preferably has, as biosurfactants, one or more of the sophorolipids described in EP2501813 with the formulae (la) and (lb).
• Sophorolipids can be used according to the invention in their acid form or in their lactone form.
• the term "acid form" of sophorolipids refers to the general formula (la) of EP2501813; the term “lactone form” of sophorolipids refers to the general formula (lb) of EP2501813.
• compositions according to the invention comprise as biosurfactant a sophorolipid in which the weight ratio of lactone form to the acid form is in the range from 20 - 80 to 80 - 20, most preferably in the ranges from 30 - 70 to 40 - 60.
• rhamnolipid in the context of the present invention is understood to mean particularly compounds of th
• n 1 or 0,
• rhamnolipids are converted by acidification into the protonated form (cf. general formula (I)) and quantified by HPLC.
• a composition preferred according to the invention is characterized in that it comprises a mixture of rhamnolipids, where the weight ratio of di-rhamnolipids to mono-rhamnolipids in the mixture is greater than 51 :49, preferably greater than 75:25, particularly preferably greater 90: 10, , particularly preferably greater 97:3particularly preferably greater than 98:2.
• a composition preferred according to the invention is characterized in that the rhamnolipid mixture, in addition to the diRL-C10C10 and monoRL-C10C10 contents mentioned above, comprises 0.5% by weight to 15% by weight, preferably 3% by weight to 12% by weight, particularly preferably 5% by weight to 10% by weight, of diRL-C10C12: 1 ,
• a composition preferred according to the invention is characterized in that the rhamnolipid mixture, in addition to the diRL-C10C10 and monoRL-C10C10 contents mentioned above, comprises 0.1 % by weight to 5% by weight, preferably 0.5% by weight to 3% by weight, particularly preferably 0.5% by weight to 2% by weight, of monoRL-C10C12 and/or, preferably and
• the rhamnolipid mixture present in the composition according to the invention in addition to the diRL-C10C10 and monoRL-C10C10 contents mentioned above, comprises
• the composition according to the invention preferably has, the fluoride ion source selected from the group consisting of stannous fluoride, sodium fluoride, potassium fluoride, potassium monofluorophosphate, sodium monofluorophosphate, ammonium monofluorophosphate, sodium fluorosilicate, ammonium fluorosilicate, amine fluorides such as olaflur ( ⁇ '- octadecyltrimethylendiamine-N,N,N'-tris(2-ethanol)-dihydrofluoride) and ammonium fluoride.
• the fluoride ion source selected from the group consisting of stannous fluoride, sodium fluoride, potassium fluoride, potassium monofluorophosphate, sodium monofluorophosphate, ammonium monofluorophosphate, sodium fluorosilicate, ammonium fluorosilicate, amine fluorides such as olaflur ( ⁇ '- octadecyltrimethylendiamine-N,
• the fluoride ion source is preferably contained in the composition according to the invention in an amount sufficient to supply 50 to 25000 ppm fluoride ion , e.g., from 100 to 1000, from 200 to 500, or 250 ppm fluoride ion%, based on the total weight of the composition.
• Fluoride ion sources may be added to the compositions of the invention at a level of 0.001 wt. % to 10 wt. %, e.g., from 0.003 wt. % to 5 wt. %, 0.01 wt. % to 1 wt., or 0.05 wt. %, based on the total weight of the composition.
• weights of fluoride salts to provide the appropriate level of fluoride ion will obviously vary based on the weight of the counter ion in the salt, and one of skill in the art may readily determine such amounts.
• a preferred fluoride salt may be sodium fluoride.
• the composition according to the invention preferably is characterized in that the biosurfactant is contained in an amount from 0.005 wt. % to 20 wt. %, preferably 0.1 wt. % to 10 wt. %, more preferably 0.5 wt % to 5 wt % and particular preferably from 0.1 wt. % to 2 wt. % based on the total weight of the composition.
• the fluoride ion source should provide from about 50 ppm to about 25000 ppm, preferably from about 50 ppm to 2500 ppm fluoride, particular preferably from about 50 ppm to 250 ppm for mouthrinses and from about 250 ppm to about 1500 ppm for toothpastes and gels.
• compositions according to the invention are characterized in that the biosurfactant is selected from the group consisting of rhamnolipids in an amount from 0.1 wt. % to 2 wt. %, and the fluoride ion source is contained in an amount sufficient to supply from 50 ppm to 1500 ppm fluoride ion.
• compositions according to the invention are characterized in that they are selected from toothpastes and gels, and that the biosurfactant is selected from the group consisting of rhamnolipids in an amount from 0.1 wt. % to 2 wt. %, and the fluoride ion source is contained in an amount sufficient to supply from 500 ppm to 1500 ppm ppm fluoride ion.
• compositions according to the invention are characterized in that they are selected from mouthrinses, and that the biosurfactant is selected from the group consisting of rhamnolipids in an amount from 0.1 wt. % to 2 wt. %, and the fluoride ion source is contained in an amount sufficient to supply from 50 ppm to 250 ppm fluoride ion.
• the oral care compositions may be provided in an orally acceptable carrier or vehicle.
• the carrier can be a liquid, semi-solid, or solid phase, in the form of a mouth rinse, dentifrice (including toothpastes, toothpowders, and prophylaxis pastes), confectionaries (including lozenges, and gum), medicament, film, or any other form known to one of skill in the art. Selection of specific carrier components is dependent on the desired product form.
• an exemplary carrier is substantially liquid.
• mouthrinse includes mouthwashes, sprays and the like.
• the orally acceptable carrier typically has an aqueous phase comprising either water, or a water and alcohol, preferably ethanol, mixture.
• the oral care compositions of the present invention may further comprise additional ingredients.
• additional ingredients may include, but are not limited to, diluents, bicarbonate salts, surfactants, foam modulators, sweeteners, flavorants, pigments, colorants, antibacterial agents, anticaries agents, anticalculus, tooth whitening agents, coolants or tartar control agents, and mixtures thereof.
• An abrasive polishing material may also be included in the oral care compositions according to the present invention.
• the abrasive polishing material contemplated for use in the compositions of the present invention can be any material which does not excessively abrade dentin.
• the abrasive polishing material should be formulated in the oral composition so that it does not compromise the stability of any ingredients, such as stannous fluoride.
• Typical abrasive polishing materials include silica gels and precipitates; aluminas; phosphates including orthophosphates,
• polymetaphosphates and pyrophosphates; and mixtures thereof.
• Specific examples include dicalcium orthophosphate dihydrate, calcium pyrophosphate, tricalcium phosphate, calcium polymetaphosphate, insoluble sodium polymetaphosphate, hydrated alumina, beta calcium pyrophosphate, calcium carbonate, and resinous abrasive materials such as particulate condensation products of urea and formaldehyde, and others such as disclosed in US3070510. Mixtures of abrasives may also be used.
• Silica dental abrasives of various types are preferred because of their unique benefits of exceptional dental cleaning and polishing performance without unduly abrading tooth enamel or dentine.
• the silica abrasive polishing materials herein, as well as other abrasives generally have an average particle size ranging between about 0.1 to about 30 microns, and preferably from about 5 to about 15 microns.
• the abrasive can be precipitated silica or silica gels such as the silica xerogels described in US3538230 and US3862307. Preferred are the silica xerogels marketed under the trade name "Syloid" by the W.R. Grace & Company, Davison Chemical Division. Also preferred are the precipitated silica materials such as those marketed by the J. M. Huber
• silica dental abrasives useful in the toothpastes of the present invention are described in more detail in US4340583.
• Silica abrasives are also described in US5589160, US5603920, US5651958, US5658553 and US5716601.
• the abrasive in the toothpaste compositions described herein is generally present at a level of from about 6% to about 70% by weight of the composition.
• toothpastes contain from about 10% to about 50% of abrasive, by weight of the dentifrice composition.
• the compositions of the present invention also comprise an antibacterial or preservative agent, such as benzyl alcohol, chlorohexidine digluconate, triclosan, benzalkonium chloride, cetyl pyridinium chloride or parabens such as methylparaben or propylparaben.
• the preservative is benzyl alcohol.
• the antibacterial or preservative agent may be present in the composition in an amount of from 0.1 to 1 weight %; 0.2 to 0.5 weight %; or about 0.3 weight % by total weight of the composition.
• the oral care compositions further comprise a humectant.
• the humectant is selected from sorbitol, glycerin, xylitol, polyethylene glycol, propylene glycol, and combinations thereof.
• the humectant is glycerin.
• the humectant is sorbitol, In certain embodiments, the humectant is present in the composition in an amount of from 5 to 20 weight %; from 7 to 17 weight %; or from 8 to 13 weight %; or from 9 to 10 weight %, based on the total weight of the composition.
• the amount of humectant is calculated as the active weight of the humectant, e.g. for a composition comprising 25 weight % sorbitol (as 70 weight % aqueous solution), the concentration of humectant is 17.5 weight %.
• the composition has a pH of from 3.5 to 10.5, preferably from 8.5 to 10.5; or from 9.2 to 10.2.
• the "pH" in connection with the present invention is defined as the value which is measured for the relevant substance at 25°C after stirring for 5 minutes using a pH electrode calibrated in accordance with ISO 4319 (1977).
• the composition comprises a buffer system, which may be: (a) a combination of sodium silicate and tetrasodium pyrophosphate; (b) a combination of sodium hydroxide, sodium bicarbonate and tetrasodium pyrophosphate; or (c) a combination of sodium bicarbonate and sodium carbonate.
• a buffer system which may be: (a) a combination of sodium silicate and tetrasodium pyrophosphate; (b) a combination of sodium hydroxide, sodium bicarbonate and tetrasodium pyrophosphate; or (c) a combination of sodium bicarbonate and sodium carbonate.
• the buffer system is 0.04 to 0.5 weight % sodium hydroxide, 0.25 to 0.75 weight % sodium bicarbonate and 0.25 to 1.5 weight % tetrasodium pyrophosphate; or about 0.12 weight % sodium hydroxide, about 0.25 weight % sodium bicarbonate and about 1.25 weight % tetrasodium pyrophosphate; or about 0.06 weight % sodium hydroxide, about 0.5 weight % sodium bicarbonate and about 0.5 weight % tetrasodium pyrophosphate based on the total weight of the composition.
• the buffer system is 0.05 to 0.5 weight % sodium bicarbonate and 0.2 to 0.6 weight % sodium carbonate; or about 0.1 weight % sodium bicarbonate and 0.4 weight % sodium carbonate, based on the total weight of the composition.
• the oral care compositions of the present invention comprise at least one bicarbonate salt useful for example to impart a "clean feel" to teeth and gums due to effervescence and release of carbon dioxide. Any orally acceptable bicarbonate can be used, including without limitation, alkali metal bicarbonates such as sodium and potassium bicarbonates, ammonium bicarbonate and the like.
• the one or more additional bicarbonate salts are optionally present in a total amount of about 0.1 wt. % to about 50 wt. %, for example about 1 wt. % to 20 wt. %, by total weight of the composition.
• the oral care compositions of the invention may also comprise at least one polymeric viscosity modifier.
• Suitable polymeric viscosity modifiers include cellulose derivatives ("cellulose gums") such as carboxymethyl cellulose (CMC), methyl cellulose, hydroxyethyl cellulose, hydroxypropyl methyl cellulose, and mixtures thereof; polyvinyl pyrrolidone; xanthan; carrageenans such as iota- carrageenan, kappa-carrageenan, kappa2-carrageenan, lambda-carrageenan, and mixtures thereof; guar gum; gum karaya; gum arabic; gum tragacanth; and mixtures thereof.
• Other suitable polymeric viscosity modifiers include Carbomer 910, Carbomer 934, Carbomer 940, and Carbomer 980 and similar polymers of acrylic acid which are cross-linked with polyalcohol allyl ethers.
• the oral care compositions of the invention may also comprise at least one further (non-bio-) surfactant.
• Any orally acceptable surfactant most of which are anionic, nonionic or amphoteric, can be used.
• Suitable anionic surfactants include without limitation, water-soluble salts of C8-20 alkyl sulfates, sulfonated monoglycerides of C8-20 fatty acids, sarcosinates, taurates and the like.
• Illustrative examples of these and other classes include sodium lauryl sulfate, sodium coconut monoglyceride sulfonate, sodium lauryl sarcosinate, sodium lauryl isethionate, sodium laureth carboxylate and sodium dodecyl benzenesulfonate.
• Suitable nonionic surfactants include without limitation, poloxamers, polyoxyethylene sorbitan esters, fatty alcohol ethoxylates, alkylphenol ethoxylates, tertiary amine oxides, tertiary phosphine oxides, dialkyl sulfoxides and the like.
• Suitable amphoteric surfactants include without limitation, derivatives of C8-20 aliphatic secondary and tertiary amines having an anionic group such as carboxylate, sulfate, sulfonate, phosphate or phosphonate. Betaines may also be used, a suitable example of which is cocoamidopropyl betaine.
• One or more surfactants are optionally present in a total amount of about 0.01 wt. % to about 10 wt. %, for example, from about 0.05 wt. % to about 5 wt. %, or from about 0.1 wt. % to about 2 wt. % by total weight of the composition.
• the oral care compositions of the invention may comprise at least one foam modulator, useful for example to increase amount, thickness or stability of foam generated by the composition upon agitation.
• Any orally acceptable foam modulator can be used, including without limitation, polyethylene glycols (PEGs), also known as polyoxyethylenes.
• PEGs polyethylene glycols
• High molecular weight PEGs are suitable, including those having an average molecular weight of 200,000 to 7,000 000, for example 500,000 to 5,000,000, or 1 ,000,000 to 2,500,000.
• One or more PEGs are optionally present in a total amount of about 0.1 wt. % to about 10 wt. %, for example from about 0.2 wt. % to about 5 wt. %, or from about 0.25 wt. % to about 2 wt. %, by total weight of the composition.
• the oral care compositions of the present invention may comprise at least one sweetener (such as, for example, sodium saccharin), useful for example to enhance taste of the composition.
• One or more sweeteners are optionally present in a total amount depending strongly on the particular sweetener(s) selected, but typically 0.005 wt. % to 5 wt. %, by total weight of the composition, optionally 0.005 wt. % to 0.2 wt. %, further optionally 0.05 wt. % to 0.1 wt. % by total weight of the composition.
• compositions of the present invention may also comprise at least one flavorant, useful for example to enhance taste of the composition.
• Any orally acceptable natural or synthetic flavorant can be used, including without limitation tea flavours, vanillin, sage, marjoram, parsley oil, spearmint oil, cinnamon oil, oil of wintergreen (methylsalicylate), peppermint oil, clove oil, bay oil, anise oil, eucalyptus oil, citrus oils, fruit oils and essences including those derived from lemon, orange, lime, grapefruit, apricot, banana, grape, apple, strawberry, cherry, pineapple, etc., bean- and nut-derived flavors such as coffee, cocoa, cola, peanut, almond, etc., adsorbed and encapsulated flavorants and the like.
• ingredients that provide fragrance and/or other sensory effect in the mouth, including cooling or warming effects.
• Such ingredients illustratively include menthol, menthyl acetate, menthyl lactate, camphor, eucalyptus oil, eucalyptol, anethole, eugenol, cassia, oxanone, oirisone, propenyl guaiethol, thymol, linalool, benzaldehyde, cinnamaldehyde, N-ethyl-p-menthan-3-carboxamine, N,2,3- trimethyl-2-isopropylbutanamide, 3 -(1-menthoxy)-propane-1 ,2-diol, cinnamaldehyde glycerol acetal (CGA), menthone glycerol acetal (MGA) and the like.
• One or more flavorants are optionally present in a total amount of from about 0.01 wt. % to about 5 wt. %, for example, from about 0.03 wt. % to about 2.5 wt. %, optionally about 0.05 wt. % to about 1 .5 wt. %, further optionally about 0.1 wt. % to about 0.3 wt. % by total weight of the composition.
• compositions of the present invention may comprise at least one colorant.
• Colorants herein include pigments, dyes, lakes and agents imparting a particular luster or reflectivity such as pearling agents. Any orally acceptable colorant can be used, including without limitation titanium dioxide, zinc oxide, red, yellow, brown and black iron oxides, ferric ammonium ferrocyanide, manganese violet, ultramarine, titaniated mica, bismuth oxychloride, and the like.
• One or more colorants are optionally present in a total amount of from about 0.001 wt. % to about 20 wt. %, for example, from about 0.01 wt. % to about 10 wt. %, or from about 0.1 wt. % to about 5 wt. %, by total weight of the composition.
• compositions of the present invention may comprise a saliva stimulating agent useful, for example, in amelioration of dry mouth.
• a saliva stimulating agent useful, for example, in amelioration of dry mouth.
• Any orally acceptable saliva stimulating agent can be used, including without limitation food acids such as citric, lactic, malic, succinic, ascorbic, adipic, fumaric and tartaric acids, and mixtures thereof.
• One or more saliva stimulating agents are optionally present in saliva stimulating effective total amount.
• compositions of the present invention may include antisensitivity agents, e.g., potassium salts such as potassium nitrate, potassium bicarbonate, potassium chloride, potassium citrate, and potassium oxalate; capsaicin; eugenol; strontium salts; chloride salts and combinations thereof.
• antisensitivity agents e.g., potassium salts such as potassium nitrate, potassium bicarbonate, potassium chloride, potassium citrate, and potassium oxalate
• capsaicin eugenol
• strontium salts e.g., from about 1 wt. % to about 20 wt. % by weight based on the total weight of the composition, depending on the agent chosen.
• composition of the present invention may further comprise an antioxidant.
• an antioxidant can be used, including butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), vitamin A, carotenoids, vitamin E, flavonoids, polyphenols, ascorbic acid, herbal antioxidants, chlorophyll, melatonin, and mixtures thereof.
• compositions of the present invention may additionally optionally comprise a tartar control (anticalculus) agent as provided below.
• Tartar control agents among those useful herein include salts of the specified agents, including alkali metal and ammonium salts.
• the agents include: phosphates and polyphosphates, polyaminopropanesulfonic acid (AMPS), polyolefin sulfonates, polyolefin phosphates, diphosphonates such as azacycloalkane-2,2-diphosphonates (e.g., azacycloheptane-2,2-diphosphonic acid), N-methyl azacyclopentane-2,3-diphosphonic acid, ethane-1-hydroxy-1 , 1-diphosphonic acid (EHDP) and ethane-1-amino-1 , 1-diphosphonate, phosphonoalkane carboxylic acids and.
• AMPS polyaminopropanesulfonic acid
• EHDP 1-diphospho
• Useful inorganic phosphate and polyphosphate salts include monobasic, dibasic and tribasic sodium phosphates, sodium tripolyphosphate, tetrapolyphosphate, sodium trimetaphosphate, sodium hexametaphosphate and mixtures thereof.
• Other useful tartar control agents include polycarboxylate polymers and polyvinyl methyl ether/maleic anhydride (PVM/MA) copolymers, such as GANTREZ®.
• composition of the invention may further comprise enzymes, including endoglycosidase, papain, dextranase, mutanase, amyloglucosidase, glucose oxidase, lysozyme, lactoperoxidase, and mixtures thereof.
• the present invention further relates to the use of biosurfactants selected from the group consisting of rhamnolipids, sophorolipids, glucose lipids, cellulose lipids and trehalose lipids, preferably rhamnolipids and/or sophorolipids, particularly preferred rhamnolipids, for a reduced formation of insoluble complexes of fluoride, preferably with calcium.
• the present invention further relates to the use of biosurfactants selected from the group consisting of rhamnolipids, sophorolipids, glucose lipids, cellulose lipids and trehalose lipids, preferably rhamnolipids and/or sophorolipids, particularly preferred rhamnolipids, for a reduced staining of teeth.
• the present invention further relates to the use of biosurfactants selected from the group consisting of rhamnolipids, sophorolipids, glucose lipids, cellulose lipids and trehalose lipids, preferably rhamnolipids and/or sophorolipids, particularly preferred rhamnolipids, for an improved deposition/retention of fluoride on surfaces, especially teeth.
• Preferred use according to the invention uses the preferred oral care compositions mentioned above.
• Example 1a Reduced oral malodour after smoking
• the first example demonstrates that the combination of Rhamnolipid and Fluoride reduces oral malodor caused by cigarette smoking.
• the breath of 24 smokers was evaluated on the basis of a sensory analysis performed by a trained panel of ten experts.
• the group of 24 smokers was subdivided into three subgroups, 1 , 2, and 3, of 8 smokers each.
• the smokers rinsed their mouth with 20 ml of mouth rinse A (subgroup 1 ), B (subgroup 2) or C (subgroup 3) for 30 seconds.
• the malodour after cigarette smoking was significantly reduced when the smokers rinsed their mouths with a mouth rinse comprising both Rhamnolipid and Fluoride prior to smoking.
• Example 1b Reduced oral malodour after smoking
• the breath of 24 smokers was evaluated on the basis of a sensory analysis performed by a trained panel of ten experts.
• the group of 24 smokers was subdivided into three subgroups, 1 , 2, and 3, of 8 smokers each.
• the smokers rinsed their mouth with 20 ml of mouth rinse A (subgroup 1 ), B (subgroup 2) or C (subgroup 3) for 30 seconds.
• the malodour after cigarette smoking was significantly reduced when the smokers rinsed their mouths with a mouth rinse comprising both Sophorolipid and Fluoride prior to smoking.
• Example 1c Reduced oral malodour after smoking
• the breath of 24 smokers was evaluated on the basis of a sensory analysis performed by a trained panel of ten experts.
• the group of 24 smokers was subdivided into three subgroups, 1 , 2, and 3, of 8 smokers each.
• the smokers rinsed their mouth with 20 ml of mouth rinse A (subgroup 1 ), B (subgroup 2) or C (subgroup 3) for 30 seconds.
• formulation G (not formulation H formulation I according to the (not according (according to
• the malodour after cigarette smoking was significantly reduced when the smokers rinsed their mouths with a mouth rinse comprising both Celluloselipid and Fluoride prior to smoking.
• Example 2a Improved taste after tooth brushing
• Toothpaste Toothpaste Toothpaste formulation A (not formulation B (not formulations C according to the according to the (according to the invention) invention) invention) Scoring 3 min after
• tooth brushing mean 1 , 1 1 ,3 2,5 values
• the taste of orange juice was significantly less bitter after tooth brushing if the toothpaste comprises both Rhamnolipid and Fluoride.
• Example 2b Improved taste after tooth brushing
• the taste of orange juice was significantly less bitter after tooth brushing if the toothpaste comprises both Sophorolipid and Fluoride.
• Example 2c Improved taste after tooth brushing
• formulation G (not formulation H formulations I according to the (not according (according to
• Titanium dioxide 0,40 0,40 0,40
• Table L Results of the taste analysis after tooth brushing and drinking orange juice
• the taste of orange juice was significantly less bitter after tooth brushing if the toothpaste comprises both Trehaloselipid and Fluoride.
• the following example demonstrates that the presence of fluoride in a toothpaste formulation does not lead to a reduction in foam volume in a Rhamnolipid or Sophorolipid containing chassis formulation if Calcium is available (e.g. from water hardness), whereas the foam volume is reduced in a SLS or CAPB containing chassis formulation in the presence of calcium from water hardness.
• the evaluation was conducted by means of a paired sensory comparison test for the descriptor of foam volume (blinded study, toothpaste formulation pairs randomized). Ten panelists brushed their teeth with a mixture of 5 g water and 1 g of a toothpaste containing one of the toothpastes in Table M or N by means of manual toothbrushes (Dr. Best original stoff) for 30 sec.
• the toothpastes were either mixed with a solution containing CaCk (316,6 mg/L egual to 2,85 mmol/L of Ca 2+ egual to 16°dH (German Hardness) or NaCI (166,7 mg/L egual to 2,85 mmol/L Na + ).
• Demineralized water was used to prepare the salt solutions. After rinsing thoroughly with 200 ml of water the panelists brushed their teeth with the corresponding toothpaste from the other table in the same manner as before. The panelists were asked to compare the foam volumes of the two toothpaste formulations. Results of the paired foam tests are first presented for the tests in which the toothpaste was diluted with water containing CaCk (Tables O, P, Q, R) and then with water containing NaCI (Tables S, T, U, V).
• Titanium dioxide 0,40 0,40 0,40 0,40
• Titanium dioxide 0,40 0,40 0,40 0,40
• Foam volume L1 > L2 Foam volume L1 L2 Foam volume L1 ⁇ L2
• Sophorolipid containing toothpaste formulation has no influence on the foam volume independent of the water hardness of the water which is used during the application, whereas the foam volume is reduced in the corresponding formulations containing fluoride and SLS or fluoride and CAPB.
• the reduction of foam is believed to be caused by the precipitation of Calcium-Flouride; the precipation has thus two negative impacts: i) the foam volume is reduced which has impact on the sensorial guality of the toothpaste during application ii) Flouride which is precipitated by calcium is not available for the remineralization and the formation of the fluorapatite mineral phase.
• compositions are made using conventional methods.
• the pH value if necessary, was adjusted by addition of either aqueous sodium hydroxide or citric acid.
• Example formulation 1 a,b Toothpaste
• Titanium dioxide 0.4 0.4
• Example formulation 3 a,b Toothpaste
• Flavor 1.0 1.0
• Example formulation 8 Toothpaste
• Calendula Officinalis Flower Extract 0.2 Chamomilla Recutita Flower Extract 0.2
• Example formulation 1 1 Toothpaste
• Example formulation 16 Toothpaste
• Example formulation 21 Toothpaste
• Example formulation 24 Toothpaste
• Example formulation 28 Toothpaste
• Example formulation 30 Toothpaste
• Example formulation 31 a,b Toothpaste for Kids
• Example formulation 35 Kids Toothpaste
• Example formulation 36 a,b 2 in 1 Toothpaste + Mouthwash
• Example formulation 38 a,b Mouthrinse without Alcohol
• Example formulation 39 Mouthrinse without Alcohol
• Example formulation 40 Mouthrinse without Alcohol
• Example formulation 43 a,b Mouthrinse without Alcohol
• Mentha Arvensis Leaf Oil 0.05 0.05
• Example formulation 44 a,b Mouthrinse without Alcohol
• Example formulation 45 Mouthrinse without Alcohol
• Example formulation 46 Mouthrinse without Alcohol
• Example formulation 48 Mouthrinse without Alcohol
• Example formulation 49 Mouthrinse without Alcohol

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Birds (AREA)
• Epidemiology (AREA)
• Chemical & Material Sciences (AREA)
• Inorganic Chemistry (AREA)
• Oral & Maxillofacial Surgery (AREA)
• Cosmetics (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=58016606

Family Applications (1)

Country Status (5)

Families Citing this family (34)

Family Cites Families (66)

• 2018
  • 2018-01-31 US US16/470,411 patent/US11464717B2/en active Active
  • 2018-01-31 WO PCT/EP2018/052335 patent/WO2018145966A1/en unknown
  • 2018-01-31 JP JP2019543372A patent/JP7271431B2/ja active Active
  • 2018-01-31 CN CN201880011106.8A patent/CN110267641A/zh active Pending
  • 2018-01-31 EP EP18705330.1A patent/EP3579819A1/de active Pending

Also Published As

Similar Documents

Legal Events